Evidence map›Paper›PMID 38530970›Full record

ArticleJournal of AOAC International2024

Development of Certified Reference Material Solutions for Phytochemicals in Ginger and Kava.

Sarah M Aijaz, Zoe Ruan, Christopher Leija, Lauren A Lytwak, Shelby Waddell, Adam J Kuszak, Stephen A Wise, Uma Sreenivasan

Open access · bronzeAbstract read
In one paragraph

Article in Journal of AOAC International, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 citations in OpenAlex.

  1. Chemical standardization of kava (Pharmaceutical biology · 2026
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Sarah M AijazMilliporeSigma, 811 Paloma Drive Suite A, Round Rock, TX 78665-2402, United States.ORCID 0000-0003-3475-2334
Zoe RuanMilliporeSigma, 811 Paloma Drive Suite A, Round Rock, TX 78665-2402, United States.ORCID 0009-0006-9456-123X
Christopher LeijaMilliporeSigma, 811 Paloma Drive Suite A, Round Rock, TX 78665-2402, United States.
Lauren A LytwakMilliporeSigma, 811 Paloma Drive Suite A, Round Rock, TX 78665-2402, United States.ORCID 0009-0001-3257-6472
Shelby WaddellMilliporeSigma, 811 Paloma Drive Suite A, Round Rock, TX 78665-2402, United States.ORCID 0000-0002-6021-1032
Adam J KuszakU.S. Department of Health and Human Services, National Institutes of Health, Office of Dietary Supplements, 6705 Rockledge Drive, Bethesda, MD 20817, United States.ORCID 0000-0001-8719-145X
Stephen A WiseU.S. Department of Health and Human Services, National Institutes of Health, Office of Dietary Supplements, 6705 Rockledge Drive, Bethesda, MD 20817, United States.ORCID 0000-0002-0021-1970
Uma SreenivasanMilliporeSigma, 811 Paloma Drive Suite A, Round Rock, TX 78665-2402, United States.ORCID 0009-0003-8035-019X
DELL (United States) · USNational Institutes of Health · US

Funding

National Institutes of Health Office of Dietary Supplements 75N98019P00918
6 · The paper itself

Abstract

backgroundDietary supplements derived from botanicals are commonly consumed and investigated in biomedical studies for their potential health benefits. Accurate identification and quantification of key chemical constituents from botanical ingredients is necessary for consistent product preparations and reproducible research results. Manufacturers need quantitative reference materials of the chemical constituents of interest to verify the content of ingredients and products. The rigor and reproducibility of biomedical research is enhanced through thorough characterization of the interventions used in mechanistic, clinical, and safety investigations. Quantitative reference materials enable reliable product quality assessments and reproducible research results.

objectiveSolution-based certified reference material (CRM) mixes were developed as calibrants for phytochemicals in ginger and kava. The kava CRM contained yangonin, desmethoxyyangonin, dihydrokavain, DL-kavain, methysticin, dihydromethysticin, flavokawain A, flavokawain B, and flavokawain C. The ginger CRM contained 6-gingerol, 8-gingerol, 10-gingerol, 6-shogaol, 8-shogaol, and 10-shogaol.

methodsEach phytochemical was sourced as an isolated compound and assigned a purity factor by a mass balance approach accounting for residual impurities. The solution standard mixes were formulated by gravimetric addition of each phytochemical incorporating the purity factor and diluting with acetonitrile to the target concentrations of 500 µg/mL for the gingerols and shogaols, 250 µg/mL for the kavalactones, and 25 µg/mL for the flavokawains.

resultsThe concentration accuracy of each component in the solution mixes was analytically verified by ultra high performance liquid chromatography with ultraviolet detection (UHPLC-UV) assay comparison to an independently prepared calibration solution. Each component in the ginger and kava CRMs were within 5 and 7% of the target concentrations, respectively.

conclusionHomogeneous kava and ginger phytochemical solution mixes were produced with accurate constituent concentrations and demonstrated good stability over 2 years. These solution mixes were launched as commercially available CRMs. HIGHLIGHTS: These mixes can be used as accurate concentration stock solutions to prepare calibrators and controls for botanical dietary supplement product testing and standardization.

Indexed as

Fatty AlcoholsKavaPhytochemicalsReference StandardsZingiber officinaleCatecholsChromatography, High Pressure LiquidDietary Supplements8-gingerolCatecholsFatty AlcoholsgingerolPhytochemicalsshogaol

Identifiers

PMID38530970
PMCPMC12102604
OpenAlexW4393180358

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.